Common use of DOCUMENTATION AND IDENTIFICATION Clause in Contracts

DOCUMENTATION AND IDENTIFICATION. 11.1. The Supplier shall, at its own risk and expense, obtain any export license or other official authorization and carry out formalities necessary for the exportation of the Products. 11.2. The Supplier shall submit the following documents to the i+solutions freight forwarder in case of EXW and FCA Incoterms: a) one (1) copy of itemized invoice; b) one (1)copy of Packing List; c) one (1) copy of the Clean Report of Findings (CRF) issued by the contracted Quality Control Agent (if applicable) d) one (1) copy of the Certificate of Analysis (CoA) for each batch delivered e) any other document/certificates required by i+solutions for export/import of the Products, e.g. DCGI (if applicable) Certificate of Origin, Certificate of Pharmaceutical Product, as specified by i+solutions in the Shipping Instructions. 11.3. In case of DAP MEG warehouse in Netherlands or DPU to GMSDs in India, one set of documents as specified in the Shipping Instructions should be sent along with the consignment. 11.4. Invoice and Packing List should clearly indicate the i+solutions Purchase Order number, i+solutions item code, unit price and total price for EXW/FCA/DAP/DPU as applicable in the invoice as per Purchase Order and country of destination. On a case by case basis, if needed, the Supplier may request i+solutions to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the i+solutions and the GDF. 11.5. The Certificate of Analysis must be as per regulatory authority approved specifications (BP, USP, Ph. Eur., or Ph. Int.) and issued by the manufacturer's own Quality Control Laboratory covering each batch delivered and to be submitted along with shipping documents. The Certificate of Analysis shall include all aspects of the Finished Pharmaceutical Product testing and be aligned with the module certificate as approved by the regulatory authority.

DOCUMENTATION AND IDENTIFICATION. 11.1. 10.1 The Supplier shall, at its own risk and expense, obtain any export license or other official authorization and carry out formalities necessary for the exportation of the Products. 11.2. 10.2 The Supplier shall submit the following documents to the i+solutions XXX freight forwarder in case of EXW and FCA IncotermsINCOTERMS: a) one four (14) copy copies of itemized invoice; b) one four (1)copy 4) copies of Packing List; c) one (1) copy of the Clean Report of Findings (CRF) issued by the contracted Quality Control Agent (if applicable) d) one (1) copy of the Certificate of Analysis (CoA) for each batch delivered e) any other document/certificates required by i+solutions for export/import of the Products, e.g. DCGI (if applicable) Certificate of Origin, Certificate of Pharmaceutical Product, as specified by i+solutions XXX in the Shipping Instructions. 11.3Purchase Order. In case of DAP MEG warehouse in Netherlands or DPU to GMSDs in IndiaINCOTERM (including offloading), one set of documents as specified in the Shipping Instructions Purchase Order should be sent along with the consignment. 11.4. 10.3 Invoice and Packing List should clearly indicate the i+solutions XXX Purchase Order number, i+solutions XXX item code, unit price and total price for EXW/FCA/DAP/DPU as applicable in the invoice as per Purchase Order code and country of destination. On a case by case basis, if needed, the Supplier may request i+solutions XXX to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the i+solutions XXX and the GDF. 11.5. 10.4 The Certificate of Analysis must be as per regulatory authority approved specifications (BP, USP, Ph. Eur., or Ph. Int., or USP) and issued by the manufacturer's own Quality Control Laboratory covering each batch delivered and to be submitted along with shipping documents. The Certificate of Analysis shall include all aspects of the Finished Pharmaceutical Product testing and be aligned with the module certificate as approved by the regulatory authority.

DOCUMENTATION AND IDENTIFICATION. 11.1. 10.1 The Supplier shall, at its own risk and expense, obtain any export license or other official authorization and carry out formalities necessary for the exportation of the Products. 11.2. 10.2 The Supplier shall submit the following documents to the i+solutions freight forwarder in case of EXW and FCA Incoterms: a) one four (14) copy copies of itemized invoice; b) one four (1)copy 4) copies of Packing List; c) one (1) copy of the Clean Report of Findings (CRF) issued by the contracted Quality Control Agent (if applicable) d) one (1) copy of the Certificate of Analysis (CoA) for each batch delivered e) any other document/certificates required by i+solutions for export/import of the Products, e.g. DCGI (if applicable) Certificate of Origin, Certificate of Pharmaceutical Product, as specified by i+solutions in the Shipping Instructions. 11.3Purchase Order. In case of DAP MEG warehouse in Netherlands or DPU to GMSDs in IndiaIncoterm (including offloading), one set of documents as specified in the Shipping Instructions Purchase Order should be sent along with the consignment. 11.4. 10.3 Invoice and Packing List should clearly indicate the i+solutions Purchase Order number, i+solutions item code, unit price and total price for EXW/bifurcation between EXW and FCA/DAP/DPU as applicable DAP in the invoice as per Purchase Order and country of destination. On a case by case basis, if needed, the Supplier may request i+solutions to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the i+solutions and the GDF. 11.5. 10.4 The Certificate of Analysis must be as per regulatory authority approved specifications (BP, USP, Ph. Eur., or Ph. Int., or USP) and issued by the manufacturer's own Quality Control Laboratory covering each batch delivered and to be submitted along with shipping documents. The Certificate of Analysis shall include all aspects of the Finished Pharmaceutical Product testing and be aligned with the module certificate as approved by the regulatory authority.

DOCUMENTATION AND IDENTIFICATION. 11.1. 10.1 The Supplier shall, at its own risk and expense, obtain any export license or other official authorization and carry out formalities necessary for the exportation of the Products. 11.2. 10.2 The Supplier shall submit the following documents to the i+solutions XXX freight forwarder in case of EXW and FCA Incoterms: a) one four (14) copy copies of itemized invoice; b) one four (1)copy 4) copies of Packing List; c) one (1) copy of the Clean Report of Findings (CRF) issued by the contracted Quality Control Agent (if applicable) d) one (1) copy of the Certificate of Analysis (CoA) for each batch delivered e) any other document/certificates required by i+solutions XXX for export/import of the Products, e.g. DCGI (if applicable) Certificate of Origin, Certificate of Pharmaceutical Product, as specified by i+solutions XXX in the Shipping Instructions. 11.3Purchase Order. In case of DAP MEG warehouse in Netherlands or DPU to GMSDs in IndiaIncoterm (including offloading), one set of documents as specified in the Shipping Instructions Purchase Order should be sent along with the consignment. 11.4. 10.3 Invoice and Packing List should clearly indicate the i+solutions XXX Purchase Order number, i+solutions XXX item code, unit price and total price for EXW/bifurcation between EXW and FCA/DAP/DPU as applicable DAP in the invoice as per Purchase Order and country of destination. On a case by case basis, if needed, the Supplier may request i+solutions XXX to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the i+solutions XXX and the GDF. 11.5. 10.4 The Certificate of Analysis must be as per regulatory authority approved specifications (BP, USP, Ph. Eur., or Ph. Int., or USP) and issued by the manufacturer's own Quality Control Laboratory covering each batch delivered and to be submitted along with shipping documents. The Certificate of Analysis shall include all aspects of the Finished Pharmaceutical Product testing and be aligned with the module certificate as approved by the regulatory authority.

DOCUMENTATION AND IDENTIFICATION. 11.1. 10.1 The Supplier shall, at its own risk and expense, obtain any export license or other official authorization and carry out formalities necessary for the exportation of the Products. 11.2. 10.2 The Supplier shall submit the following documents to the i+solutions IDA freight forwarder in case of EXW and FCA Incoterms: a) one four (14) copy copies of itemized invoice; b) one four (1)copy 4) copies of Packing List; c) one (1) copy of the Clean Report of Findings (CRF) issued by the contracted Quality Control Agent (if applicable) d) one (1) copy of the Certificate of Analysis (CoA) for each batch delivered e) any other document/certificates required by i+solutions IDA for export/import of the Products, e.g. DCGI (if applicable) Certificate of Origin, Certificate of Pharmaceutical Product, as specified by i+solutions IDA in the Shipping Instructions. 11.3Purchase Order. In case of DAP MEG warehouse in Netherlands or DPU to GMSDs in IndiaIncoterm (including offloading), one set of documents as specified in the Shipping Instructions Purchase Order should be sent along with the consignment. 11.4. 10.3 Invoice and Packing List should clearly indicate the i+solutions XXX Purchase Order number, i+solutions XXX item code, unit price and total price for EXW/bifurcation between EXW and FCA/DAP/DPU as applicable DAP in the invoice as per Purchase Order and country of destination. On a case by case basis, if needed, the Supplier may request i+solutions IDA to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the i+solutions IDA and the GDF. 11.5. 10.4 The Certificate of Analysis must be as per regulatory authority approved specifications (BP, USP, Ph. Eur., or Ph. Int., or USP) and issued by the manufacturer's own Quality Control Laboratory covering each batch delivered and to be submitted along with shipping documents. The Certificate of Analysis shall include all aspects of the Finished Pharmaceutical Product testing and be aligned with the module certificate as approved by the regulatory authority.

DOCUMENTATION AND IDENTIFICATION. 11.1. The Supplier shall, at its own risk and expense, obtain any export license or other official authorization and carry out formalities necessary for the exportation of the Products. 11.2. The Supplier shall submit the following documents to the i+solutions freight forwarder in case of EXW and FCA Incoterms: a) one four (14) copy copies of itemized invoice; b) one four (1)copy 4) copies of Packing List; c) one (1) copy of the Clean Report of Findings (CRF) issued by the contracted Quality Control Agent (if applicable) d) one (1) copy of the Certificate of Analysis (CoA) for each batch delivered e) any other document/certificates required by i+solutions for export/import of the Products, e.g. DCGI (if applicable) Certificate of Origin, Certificate of Pharmaceutical Product, as specified by i+solutions in the Shipping InstructionsPurchase Order. 11.3. In case of DAP MEG warehouse in Netherlands or DPU to GMSDs in Incoterm (including offloading for India), one set of documents as specified in the Shipping Instructions Purchase Order should be sent along with the consignment. 11.4. Invoice and Packing List should clearly indicate the i+solutions Purchase Order number, i+solutions item code, unit price and total price for EXW/EXW and FCA/DAP/DPU as applicable DAP in the invoice as per Purchase Order and country of destination. On a case by case basis, if needed, the Supplier may request i+solutions to solicit GDF’s facilitation in the export process by available means in the scope of the procurement services agreement entered between the i+solutions and the GDF. 11.5. The Certificate of Analysis must be as per regulatory authority approved specifications (BP, USP, Ph. Eur., or Ph. Int.) and issued by the manufacturer's own Quality Control Laboratory covering each batch delivered and to be submitted along with shipping documents. The Certificate of Analysis shall include all aspects of the Finished Pharmaceutical Product testing and be aligned with the module certificate as approved by the regulatory authority.